Valneva SE Stock London S.E.
Stocks
0OB3
FR0004056851
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
London S.E.
03:03:24 2026-05-14 EDT
|
5-day change | 1st Jan Change | ||
| 2.592 EUR | -38.30% |
|
+7.35% | -30.05% |
| Market Cap | 562M 657M 526M 482M 904M 62.88B 916M 6.22B 2.42B 31.56B 2.47B 2.41B 104B | P/E 2026 * |
-6.81x | P/E 2027 * | 10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 696M 813M 651M 596M 1.12B 77.82B 1.13B 7.7B 3B 39.06B 3.05B 2.99B 129B | EV / Sales 2026 * |
4.61x | EV / Sales 2027 * | 2.21x |
| Free-Float |
97.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Valneva SE
| 1 day | -38.30% | ||
| 1 week | +7.35% | ||
| Current month | +18.53% | ||
| 1 month | +19.91% | ||
| 3 months | +6.73% | ||
| 6 months | -44.47% | ||
| Current year | -30.05% |
| 1 week | 2.59 |  | 3.16 |
| 1 month | 2.04 | | 3.33 |
| Current year | 2.03 | | 5.15 |
| 1 year | 2.03 | | 5.34 |
| 3 years | 1.72 | | 7.14 |
| 5 years | 1.72 | | 29.54 |
| 10 years | 1.72 | | 29.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 2021-07-28 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2023-12-19 | |
James Sulat
BRD | Director/Board Member | 75 | 2013-03-06 |
| Chairman | 65 | 2023-12-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -38.30% | +7.35% | - | - | 648M | |
| +1.09% | +3.39% | +3.50% | +25.49% | 51.22B | |
| -1.07% | +3.69% | +479.26% | +607.16% | 45.38B | |
| +1.44% | +5.19% | +21.06% | +93.98% | 41.97B | |
| +1.47% | +7.58% | +35.29% | +21.42% | 42.15B | |
| -0.93% | -4.80% | +17.39% | +46.60% | 31.95B | |
| -0.60% | +2.87% | - | - | 16.73B | |
| +1.32% | +6.67% | +33.29% | +148.62% | 17.1B | |
| +0.03% | +3.91% | +5.84% | +35.04% | 14.76B | |
| +1.28% | +4.95% | +84.98% | +48.41% | 13.91B | |
| Average | -3.43% | +3.19% | +85.08% | +128.34% | 30.58B | |
| Weighted average by Cap. | +0.38% | +3.13% | +103.29% | +150.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 151M 176M 141M 129M 243M 16.88B 246M 1.67B 651M 8.47B 662M 648M 28.03B | 283M 331M 265M 243M 455M 31.68B 461M 3.13B 1.22B 15.9B 1.24B 1.22B 52.59B |
| Net income | -81.11M -94.73M -75.85M -69.44M -130M -9.07B -132M -897M -350M -4.55B -356M -348M -15.05B | 53.07M 61.98M 49.63M 45.43M 85.3M 5.93B 86.4M 587M 229M 2.98B 233M 228M 9.85B |
| Net Debt | 134M 156M 125M 114M 215M 14.95B 218M 1.48B 576M 7.5B 586M 573M 24.82B | 62.48M 72.96M 58.42M 53.49M 100M 6.98B 102M 691M 269M 3.51B 274M 268M 11.6B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | €2.930 | -1.88% | 36,634 |
| 26-08-20 | €2.986 | -0.31% | 702,685 |
| 26-08-19 | €2.996 | +2.62% | 34,843 |
| 26-08-18 | €2.919 | -2.59% | 33,830 |
| 26-08-17 | €2.997 | +3.19% | 88,953 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- 0OB3 Stock
Select your edition
All financial news and data tailored to specific country editions
